The hydrophilic angiographic catheters market size has grown strongly in recent years. It will grow from $13.54 billion in 2025 to $14.55 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing prevalence of cardiovascular diseases, expansion of diagnostic angiography procedures, reliance on conventional angiographic catheters, increasing hospital-based interventional procedures, advancements in catheter material science.
The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $19.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive interventions, technological innovation in hydrophilic coating technologies, growth in interventional cardiology and radiology, increasing healthcare expenditure on cardiac care, expanding access to advanced imaging and catheterization labs. Major trends in the forecast period include increasing use of hydrophilic coatings for reduced friction, rising adoption in minimally invasive cardiovascular procedures, growing preference for selective angiographic catheters, improved catheter trackability in complex vascular anatomy, enhanced focus on procedural safety and physician control.
The growth in the prevalence of renal disorders is increasingly supporting the expansion of the hydrophilic angiographic catheters market going forward. Renal disorders encompass a wide range of conditions that impair kidney function, including blood filtration, waste elimination, fluid balance, and blood pressure regulation. The rising prevalence of renal disorders is primarily associated with increasing rates of diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorder management to enable smooth and precise navigation during diagnostic and interventional procedures such as renal angiography and stenting. For example, in June 2023, according to Kidney Research UK, approximately 7.2 million people in the UK were living with chronic kidney disease, representing over 10% of the population, with projections indicating growth to 7.61 million by 2033. Consequently, the expanding prevalence of renal disorders is reinforcing growth in the hydrophilic angiographic catheters market.
Leading companies operating in the hydrophilic angiographic catheters market are focusing on developing innovative products such as catheters with multiple curve configurations to maintain their market position. Catheters with various curve configurations are engineered to navigate complex vascular anatomy more effectively. For example, in January 2024, Cook Group Incorporated, a US-based medical device company, launched the Slip-Cath Beacon Tip hydrophilic selective catheter in the US and Canada. The catheter offers more than 30 curve options, protective foil packaging for extended durability, and a three-year shelf life, enhancing procedural flexibility and compatibility with a wide range of vascular access devices.
In April 2024, Shenzhen Mindray Technology Holdings Co. Ltd., a China-based medical device company, acquired a 19.72% stake in APT Medical for $927 million. This acquisition positions Mindray as a significant participant in the cardiovascular medical device market, enabling it to leverage APT Medical’s expertise in cardiac electrophysiology and vascular intervention technologies. APT Medical is a China-based medical device company specializing in hydrophilic angiographic catheters.
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Invamed Group.
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2025. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydrophilic angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hydrophilic angiographic catheters market by increasing costs for imported raw materials, coatings, and precision manufacturing components. These impacts are most visible in selective catheter segments and in regions such as Asia-Pacific and Europe, where cross-border sourcing is common. Higher duties have led to increased device prices and margin pressure for manufacturers. However, tariffs are also encouraging localized production, supplier diversification, and innovation in cost-efficient catheter designs, supporting long-term market stability.
The hydrophilic angiographic catheters market research report is one of a series of new reports that provides hydrophilic angiographic catheters market statistics, including hydrophilic angiographic catheters industry global market size, regional shares, competitors with a hydrophilic angiographic catheters market share, detailed hydrophilic angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the hydrophilic angiographic catheters industry. This hydrophilic angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hydrophilic angiographic catheters are specialized catheters used in radiology and cardiology that feature a hydrophilic coating to reduce friction, allowing smoother navigation through complex blood vessels during diagnostic and therapeutic procedures.
The main types of hydrophilic angiographic catheters include selective angiographic catheters and non-selective angiographic catheters. Selective angiographic catheters are engineered to provide targeted access to specific blood vessels and feature various tip shapes and curves to navigate complex vascular structures and engage vessel openings. These devices are used in applications such as cardiac disease treatment, renal disease treatment, and others by end users including hospitals, diagnostic imaging centers, and others.
The hydrophilic angiographic catheters market consists of sales of guidewire, imaging equipment, contrast media injectors, and control and steering devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $19.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive interventions, technological innovation in hydrophilic coating technologies, growth in interventional cardiology and radiology, increasing healthcare expenditure on cardiac care, expanding access to advanced imaging and catheterization labs. Major trends in the forecast period include increasing use of hydrophilic coatings for reduced friction, rising adoption in minimally invasive cardiovascular procedures, growing preference for selective angiographic catheters, improved catheter trackability in complex vascular anatomy, enhanced focus on procedural safety and physician control.
The growth in the prevalence of renal disorders is increasingly supporting the expansion of the hydrophilic angiographic catheters market going forward. Renal disorders encompass a wide range of conditions that impair kidney function, including blood filtration, waste elimination, fluid balance, and blood pressure regulation. The rising prevalence of renal disorders is primarily associated with increasing rates of diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorder management to enable smooth and precise navigation during diagnostic and interventional procedures such as renal angiography and stenting. For example, in June 2023, according to Kidney Research UK, approximately 7.2 million people in the UK were living with chronic kidney disease, representing over 10% of the population, with projections indicating growth to 7.61 million by 2033. Consequently, the expanding prevalence of renal disorders is reinforcing growth in the hydrophilic angiographic catheters market.
Leading companies operating in the hydrophilic angiographic catheters market are focusing on developing innovative products such as catheters with multiple curve configurations to maintain their market position. Catheters with various curve configurations are engineered to navigate complex vascular anatomy more effectively. For example, in January 2024, Cook Group Incorporated, a US-based medical device company, launched the Slip-Cath Beacon Tip hydrophilic selective catheter in the US and Canada. The catheter offers more than 30 curve options, protective foil packaging for extended durability, and a three-year shelf life, enhancing procedural flexibility and compatibility with a wide range of vascular access devices.
In April 2024, Shenzhen Mindray Technology Holdings Co. Ltd., a China-based medical device company, acquired a 19.72% stake in APT Medical for $927 million. This acquisition positions Mindray as a significant participant in the cardiovascular medical device market, enabling it to leverage APT Medical’s expertise in cardiac electrophysiology and vascular intervention technologies. APT Medical is a China-based medical device company specializing in hydrophilic angiographic catheters.
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Invamed Group.
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2025. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydrophilic angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hydrophilic angiographic catheters market by increasing costs for imported raw materials, coatings, and precision manufacturing components. These impacts are most visible in selective catheter segments and in regions such as Asia-Pacific and Europe, where cross-border sourcing is common. Higher duties have led to increased device prices and margin pressure for manufacturers. However, tariffs are also encouraging localized production, supplier diversification, and innovation in cost-efficient catheter designs, supporting long-term market stability.
The hydrophilic angiographic catheters market research report is one of a series of new reports that provides hydrophilic angiographic catheters market statistics, including hydrophilic angiographic catheters industry global market size, regional shares, competitors with a hydrophilic angiographic catheters market share, detailed hydrophilic angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the hydrophilic angiographic catheters industry. This hydrophilic angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hydrophilic angiographic catheters are specialized catheters used in radiology and cardiology that feature a hydrophilic coating to reduce friction, allowing smoother navigation through complex blood vessels during diagnostic and therapeutic procedures.
The main types of hydrophilic angiographic catheters include selective angiographic catheters and non-selective angiographic catheters. Selective angiographic catheters are engineered to provide targeted access to specific blood vessels and feature various tip shapes and curves to navigate complex vascular structures and engage vessel openings. These devices are used in applications such as cardiac disease treatment, renal disease treatment, and others by end users including hospitals, diagnostic imaging centers, and others.
The hydrophilic angiographic catheters market consists of sales of guidewire, imaging equipment, contrast media injectors, and control and steering devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hydrophilic Angiographic Catheters Market Characteristics
3. Hydrophilic Angiographic Catheters Market Supply Chain Analysis
4. Global Hydrophilic Angiographic Catheters Market Trends and Strategies
5. Hydrophilic Angiographic Catheters Market Analysis of End Use Industries
7. Global Hydrophilic Angiographic Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hydrophilic Angiographic Catheters Total Addressable Market (TAM) Analysis for the Market
9. Hydrophilic Angiographic Catheters Market Segmentation
10. Hydrophilic Angiographic Catheters Market Regional and Country Analysis
11. Asia-Pacific Hydrophilic Angiographic Catheters Market
12. China Hydrophilic Angiographic Catheters Market
13. India Hydrophilic Angiographic Catheters Market
14. Japan Hydrophilic Angiographic Catheters Market
15. Australia Hydrophilic Angiographic Catheters Market
16. Indonesia Hydrophilic Angiographic Catheters Market
17. South Korea Hydrophilic Angiographic Catheters Market
18. Taiwan Hydrophilic Angiographic Catheters Market
19. South East Asia Hydrophilic Angiographic Catheters Market
20. Western Europe Hydrophilic Angiographic Catheters Market
21. UK Hydrophilic Angiographic Catheters Market
22. Germany Hydrophilic Angiographic Catheters Market
23. France Hydrophilic Angiographic Catheters Market
24. Italy Hydrophilic Angiographic Catheters Market
25. Spain Hydrophilic Angiographic Catheters Market
26. Eastern Europe Hydrophilic Angiographic Catheters Market
27. Russia Hydrophilic Angiographic Catheters Market
28. North America Hydrophilic Angiographic Catheters Market
29. USA Hydrophilic Angiographic Catheters Market
30. Canada Hydrophilic Angiographic Catheters Market
31. South America Hydrophilic Angiographic Catheters Market
32. Brazil Hydrophilic Angiographic Catheters Market
33. Middle East Hydrophilic Angiographic Catheters Market
34. Africa Hydrophilic Angiographic Catheters Market
36. Hydrophilic Angiographic Catheters Market Competitive Landscape and Company Profiles
37. Hydrophilic Angiographic Catheters Market Other Major and Innovative Companies
40. Hydrophilic Angiographic Catheters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hydrophilic Angiographic Catheters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hydrophilic angiographic catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hydrophilic angiographic catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hydrophilic angiographic catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Selective Type Angiographic Catheters; Non-Selective Type Angiographic Catheters2) By Application: Heart Disease Treatment; Kidney Disease Treatment; Other Applications
3) By End User: Hospitals; Diagnostic And Imaging Centers; Other End-Users
Subsegments:
1) By Selective Type Angiographic Catheters: Coronary Selective Catheters; Peripheral Selective Catheters; Neuro Selective Catheters2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters; Non-Selective Peripheral Catheters; Non-Selective Neuro Catheters
Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic plc; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Cook Medical Inc.; Teleflex Incorporated; Lepu Medical Technology (Beijing) Co Ltd.; Merit Medical Systems Inc.; Cordis Corporation; MicroPort Scientific Corporation; Asahi Intecc Co Ltd.; AngioDynamics Inc.; Alvimedica Medical Technologies; BrosMed Medical Co Ltd.; iVascular SLU; Hexacath; Invamed Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hydrophilic Angiographic Catheters market report include:- Cardinal Health Inc.
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson and Company
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Cook Medical Inc.
- Teleflex Incorporated
- Lepu Medical Technology (Beijing) Co Ltd.
- Merit Medical Systems Inc.
- Cordis Corporation
- MicroPort Scientific Corporation
- Asahi Intecc Co Ltd.
- AngioDynamics Inc.
- Alvimedica Medical Technologies
- BrosMed Medical Co Ltd.
- iVascular SLU
- Hexacath
- Invamed Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.55 Billion |
| Forecasted Market Value ( USD | $ 19.13 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
